112 related articles for article (PubMed ID: 34304115)
1. The significance of HOXB7 and IL17RB serum levels in prognosis of hormonally dependent breast cancer: A pilot study.
Todorović-Raković N; Milovanović J; Greenman J; Radulovic M
Adv Med Sci; 2021 Sep; 66(2):359-365. PubMed ID: 34304115
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of serum interferon-gamma (IFN-γ) in hormonally dependent breast cancer.
Todorović-Raković N; Milovanović J; Greenman J; Radulovic M
Cytokine; 2022 Apr; 152():155836. PubMed ID: 35219004
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer.
Milovanović J; Todorović-Raković N; Radulovic M
Cytokine; 2019 Jun; 118():93-98. PubMed ID: 29482885
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.
Komatsu H; Iguchi T; Masuda T; Ueda M; Kidogami S; Ogawa Y; Nambara S; Sato K; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Anticancer Res; 2016 Jun; 36(6):2767-73. PubMed ID: 27272787
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
Jankowitz RC; Cooper K; Erlander MG; Ma XJ; Kesty NC; Li H; Chivukula M; Brufsky A
Breast Cancer Res; 2011 Oct; 13(5):R98. PubMed ID: 21999244
[TBL] [Abstract][Full Text] [Related]
7. The relationship between homeobox B7 expression and the clinical characteristics of patient with prostate cancer.
Song Z; Liao Z; Cui Y; Yang C
J Cell Biochem; 2019 Apr; 120(4):6395-6401. PubMed ID: 30317675
[TBL] [Abstract][Full Text] [Related]
8. Deregulated HOXB7 expression predicts poor prognosis of patients with malignancies of digestive system.
Liu FT; Chen HM; Xiong Y; Zhu ZM
Minerva Chir; 2019 Oct; 74(5):422-430. PubMed ID: 28749115
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.
Guo Y; Qin X; Chai B; Jia J; Yi J; Wang K; Hou X
Int J Clin Exp Pathol; 2019; 12(7):2682-2690. PubMed ID: 31934098
[TBL] [Abstract][Full Text] [Related]
10. The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.
Jin K; Kong X; Shah T; Penet MF; Wildes F; Sgroi DC; Ma XJ; Huang Y; Kallioniemi A; Landberg G; Bieche I; Wu X; Lobie PE; Davidson NE; Bhujwalla ZM; Zhu T; Sukumar S
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2736-41. PubMed ID: 21690342
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
[TBL] [Abstract][Full Text] [Related]
12. HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.
Jin K; Park S; Teo WW; Korangath P; Cho SS; Yoshida T; Győrffy B; Goswami CP; Nakshatri H; Cruz LA; Zhou W; Ji H; Su Y; Ekram M; Wu Z; Zhu T; Polyak K; Sukumar S
Cancer Discov; 2015 Sep; 5(9):944-59. PubMed ID: 26180042
[TBL] [Abstract][Full Text] [Related]
13. Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo.
Li H; Shen LY; Yan WP; Dong B; Kang XZ; Dai L; Yang YB; Fu H; Yang HL; Zhou HT; Huang C; Liang Z; Xiong HC; Chen KN
PLoS One; 2015; 10(6):e0130551. PubMed ID: 26076456
[TBL] [Abstract][Full Text] [Related]
14. HOXB7 predicts poor clinical outcome in patients with advanced esophageal squamous cell cancer.
Long QY; Zhou J; Zhang XL; Cao JH
Asian Pac J Cancer Prev; 2014; 15(4):1563-6. PubMed ID: 24641368
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HOXB7 is associated with a poor prognosis in patients with gastric cancer.
Tu W; Zhu X; Han Y; Wen Y; Qiu G; Zhou C
Oncol Lett; 2015 Nov; 10(5):2967-2973. PubMed ID: 26722273
[TBL] [Abstract][Full Text] [Related]
16. Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients.
Zhang R; Zheng S; Du Y; Wang Y; Zang W; Zhao G
Diagn Pathol; 2014 Mar; 9():61. PubMed ID: 24641834
[TBL] [Abstract][Full Text] [Related]
17. HOXB7-S3 inhibits the proliferation and invasion of MCF-7 human breast cancer cells.
Ma R; Zhang D; Hu PC; Li Q; Lin CY
Mol Med Rep; 2015 Oct; 12(4):4901-8. PubMed ID: 26135503
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
19. HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.
Wu X; Li J; Yan T; Ke X; Li X; Zhu Y; Yang J; Li Z
Cancer Cell Int; 2021 Jul; 21(1):393. PubMed ID: 34303375
[TBL] [Abstract][Full Text] [Related]
20. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
